FRM
Fox Run Management’s FibroGen FGEN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-42,720
| Closed | -$36.9K | – | 818 |
|
2023
Q3 | $36.9K | Buy |
+42,720
| New | +$36.9K | 0.01% | 662 |
|
2022
Q1 | – | Sell |
-16,384
| Closed | -$231K | – | 569 |
|
2021
Q4 | $231K | Buy |
+16,384
| New | +$231K | 0.14% | 315 |
|
2020
Q1 | – | Sell |
-4,789
| Closed | -$205K | – | 199 |
|
2019
Q4 | $205K | Buy |
+4,789
| New | +$205K | 0.17% | 321 |
|
2018
Q4 | – | Sell |
-8,000
| Closed | -$486K | – | 580 |
|
2018
Q3 | $486K | Buy |
+8,000
| New | +$486K | 0.21% | 181 |
|
2018
Q2 | – | Sell |
-6,674
| Closed | -$308K | – | 748 |
|
2018
Q1 | $308K | Buy |
+6,674
| New | +$308K | 0.07% | 484 |
|
2017
Q4 | – | Sell |
-17,500
| Closed | -$942K | – | 740 |
|
2017
Q3 | $942K | Buy |
+17,500
| New | +$942K | 0.27% | 83 |
|
2017
Q2 | – | Sell |
-23,305
| Closed | -$574K | – | 691 |
|
2017
Q1 | $574K | Buy |
+23,305
| New | +$574K | 0.23% | 139 |
|
2016
Q4 | – | Sell |
-12,300
| Closed | -$255K | – | 552 |
|
2016
Q3 | $255K | Buy |
12,300
+1,600
| +15% | +$33.2K | 0.15% | 319 |
|
2016
Q2 | $176K | Buy |
+10,700
| New | +$176K | 0.09% | 461 |
|